NASDAQ:MEDP - Medpace Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$42.62 +1.31 (+3.17 %)
(As of 05/20/2018 03:52 PM ET)
Previous Close$42.62
Today's Range$41.49 - $43.13
52-Week Range$26.19 - $43.13
Volume209,908 shs
Average Volume353,368 shs
Market Capitalization$1.51 billion
P/E Ratio28.04
Dividend YieldN/A
Beta0.07

About Medpace (NASDAQ:MEDP)

Medpace logoMedpace Holdings, Inc., a clinical contract research organization, provides scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries worldwide. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in a range of therapeutic areas. Its clinical development services include medical affairs, clinical trial management, feasibility and start-up study, clinical monitoring, global regulatory affairs, medical writing, biometrics, pharmacovigilance, core laboratory, and quality assurance. Medpace Holdings, Inc. was founded in 1992 and is headquartered in Cincinnati, Ohio.

Receive MEDP News and Ratings via Email

Sign-up to receive the latest news and ratings for MEDP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Commercial physical research
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:MEDP
CUSIPN/A
Phone513-579-9911

Debt

Debt-to-Equity Ratio0.41
Current Ratio0.66
Quick Ratio0.66

Price-To-Earnings

Trailing P/E Ratio28.04
Forward P/E Ratio22.20
P/E Growth1.59

Sales & Book Value

Annual Sales$436.15 million
Price / Sales3.47
Cash Flow$2.6292 per share
Price / Cash16.21
Book Value$14.39 per share
Price / Book2.96

Profitability

EPS (Most Recent Fiscal Year)$1.52
Net Income$39.12 million
Net Margins10.37%
Return on Equity12.50%
Return on Assets7.08%

Miscellaneous

Employees2,500
Outstanding Shares35,510,000

Medpace (NASDAQ:MEDP) Frequently Asked Questions

What is Medpace's stock symbol?

Medpace trades on the NASDAQ under the ticker symbol "MEDP."

How were Medpace's earnings last quarter?

Medpace Holdings (NASDAQ:MEDP) announced its quarterly earnings data on Monday, April, 30th. The company reported $0.60 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.43 by $0.17. The firm earned $108.40 million during the quarter, compared to the consensus estimate of $113.12 million. Medpace had a return on equity of 12.50% and a net margin of 10.37%. The business's revenue for the quarter was up 15.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.34 EPS. View Medpace's Earnings History.

When is Medpace's next earnings date?

Medpace is scheduled to release their next quarterly earnings announcement on Monday, July, 30th 2018. View Earnings Estimates for Medpace.

What guidance has Medpace issued on next quarter's earnings?

Medpace issued an update on its FY18 earnings guidance on Monday, April, 30th. The company provided earnings per share (EPS) guidance of $1.87-1.97 for the period, compared to the Thomson Reuters consensus estimate of $1.88. The company issued revenue guidance of $421-435 million, compared to the consensus revenue estimate of $463.04 million.

What price target have analysts set for MEDP?

8 brokerages have issued 1 year price objectives for Medpace's shares. Their forecasts range from $35.00 to $42.00. On average, they anticipate Medpace's stock price to reach $37.40 in the next year. View Analyst Ratings for Medpace.

Who are some of Medpace's key competitors?

Who are Medpace's key executives?

Medpace's management team includes the folowing people:
  • Dr. August James Troendle, Chairman, Chief Exec. Officer and Pres (Age 62)
  • Mr. Jesse J. Geiger BBA, CPA, Chief Financial Officer and Chief Operating Officer of Laboratory Operations (Age 44)
  • Ms. Susan E. Burwig MA, BSN, Exec. VP of Operations (Age 55)
  • Mr. Stephen P. Ewald J.D., Gen. Counsel and Corp. Sec. (Age 49)
  • Mr. Todd Meyers, VP of Bus. Devel. and Marketing

When did Medpace IPO?

(MEDP) raised $150 million in an initial public offering (IPO) on Thursday, August 11th 2016. The company issued 7,000,000 shares at a price of $20.00-$23.00 per share. Jefferies, Credit Suisse, UBS Investment Bank and Wells Fargo Securities acted as the underwriters for the IPO and Baird and William Blair were co-managers.

Has Medpace been receiving favorable news coverage?

Media coverage about MEDP stock has trended somewhat positive recently, according to Accern Sentiment Analysis. The research firm rates the sentiment of news coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Medpace earned a news impact score of 0.23 on Accern's scale. They also assigned press coverage about the company an impact score of 46.64 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

Who are Medpace's major shareholders?

Medpace's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include CINVEN CAPITAL MANAGEMENT (V) GENERAL PARTNER LTD (37.70%), BlackRock Inc. (3.42%), Bernzott Capital Advisors (1.95%), UBS Group AG (0.91%), Granite Investment Partners LLC (0.73%) and Prudential Financial Inc. (0.50%). Company insiders that own Medpace stock include August J Troendle, Medpace Limited Partnership and Susan E Burwig. View Institutional Ownership Trends for Medpace.

Which institutional investors are selling Medpace stock?

MEDP stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Alambic Investment Management L.P., Hsbc Holdings PLC, Federated Investors Inc. PA, Granite Investment Partners LLC, Thrivent Financial for Lutherans, Bernzott Capital Advisors and Wells Fargo & Company MN. View Insider Buying and Selling for Medpace.

Which institutional investors are buying Medpace stock?

MEDP stock was purchased by a variety of institutional investors in the last quarter, including UBS Group AG, Dimensional Fund Advisors LP, American Century Companies Inc., Prudential Financial Inc., BlackRock Inc., Russell Investments Group Ltd., Allianz Asset Management GmbH and Systematic Financial Management LP. Company insiders that have bought Medpace stock in the last two years include August J Troendle and Susan E Burwig. View Insider Buying and Selling for Medpace.

How do I buy shares of Medpace?

Shares of MEDP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Medpace's stock price today?

One share of MEDP stock can currently be purchased for approximately $42.62.

How big of a company is Medpace?

Medpace has a market capitalization of $1.51 billion and generates $436.15 million in revenue each year. The company earns $39.12 million in net income (profit) each year or $1.52 on an earnings per share basis. Medpace employs 2,500 workers across the globe.

How can I contact Medpace?

Medpace's mailing address is 5375 MEDPACE WAY, CINCINNATI OH, 45227. The company can be reached via phone at 513-579-9911 or via email at [email protected]


MarketBeat Community Rating for Medpace (MEDP)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  131 (Vote Outperform)
Underperform Votes:  125 (Vote Underperform)
Total Votes:  256
MarketBeat's community ratings are surveys of what our community members think about Medpace and other stocks. Vote "Outperform" if you believe MEDP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MEDP will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Medpace (NASDAQ:MEDP) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
8 Wall Street analysts have issued ratings and price targets for Medpace in the last 12 months. Their average twelve-month price target is $37.40, suggesting that the stock has a possible downside of 12.25%. The high price target for MEDP is $42.00 and the low price target for MEDP is $35.00. There are currently 7 hold ratings and 1 buy rating for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.132.132.142.14
Ratings Breakdown: 0 Sell Rating(s)
7 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
7 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $37.40$37.40$35.75$35.75
Price Target Upside: 12.25% downside1.36% upside4.59% downside4.59% downside

Medpace (NASDAQ:MEDP) Consensus Price Target History

Price Target History for Medpace (NASDAQ:MEDP)

Medpace (NASDAQ:MEDP) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/20/2018Mitsubishi UFJ Financial GroupReiterated RatingNeutral$40.00LowView Rating Details
4/10/2018Robert W. BairdSet Price TargetHold$35.00HighView Rating Details
3/1/2018Jefferies GroupReiterated RatingHold$35.00LowView Rating Details
2/28/2018Wells FargoLower Price TargetMarket Perform ➝ Market Perform$38.00 ➝ $35.00MediumView Rating Details
2/27/2018Credit Suisse GroupReiterated RatingOutperform ➝ Outperform$41.00 ➝ $42.00HighView Rating Details
11/1/2017William BlairDowngradeOutperform ➝ Market PerformN/AView Rating Details
10/17/2017KeyCorpReiterated RatingHoldN/AView Rating Details
9/29/2017Raymond JamesInitiated CoverageMkt Perform ➝ Market PerformLowView Rating Details
9/6/2016UBSInitiated CoverageBuy$35.00N/AView Rating Details
(Data available from 5/20/2016 forward)

Earnings

Medpace (NASDAQ:MEDP) Earnings History and Estimates Chart

Earnings by Quarter for Medpace (NASDAQ:MEDP)

Medpace (NASDAQ:MEDP) Earnings Estimates

2018 EPS Consensus Estimate: $1.76
2019 EPS Consensus Estimate: $2.22
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20183$0.42$0.43$0.43
Q2 20183$0.39$0.42$0.40
Q3 20183$0.43$0.47$0.45
Q4 20183$0.45$0.50$0.47
Q1 20191$0.51$0.51$0.51
Q2 20191$0.52$0.52$0.52
Q3 20191$0.57$0.57$0.57
Q4 20191$0.62$0.62$0.62

Medpace (NASDAQ MEDP) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/30/2018$0.44N/AView Earnings Details
4/30/2018Q1 2018$0.43$0.60$113.12 million$108.40 millionViewListenView Earnings Details
2/26/2018Q4 2017$0.38$0.39$97.25 million$99.45 millionViewListenView Earnings Details
10/30/2017Q3 2017$0.36$0.40$96.84 million$98.68 millionViewN/AView Earnings Details
7/31/2017Q2 2017$0.30$0.38$92.71 million$94.60 millionViewN/AView Earnings Details
5/1/2017Q1 2017$0.37$0.34$93.61 million$93.80 millionViewListenView Earnings Details
2/27/2017Q416$0.34$0.35$94.40 million$95.38 millionViewListenView Earnings Details
11/3/2016Q316$0.34$0.40$91.42 million$94.80 millionViewListenView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Medpace (NASDAQ:MEDP) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Medpace (NASDAQ MEDP) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 29.50%
Institutional Ownership Percentage: 25.48%
Insider Trading History for Medpace (NASDAQ:MEDP)
Institutional Ownership by Quarter for Medpace (NASDAQ:MEDP)

Medpace (NASDAQ MEDP) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/7/2018Medpace Limited PartnershipMajor ShareholderSell3,000,000$35.49$106,470,000.00View SEC Filing  
12/5/2017Medpace Limited PartnershipMajor ShareholderSell4,600,000$30.16$138,736,000.00View SEC Filing  
8/22/2017Medpace Limited PartnershipMajor ShareholderSell2,000,000$30.27$60,540,000.00View SEC Filing  
8/18/2016August J TroendleCEOBuy10,000$27.98$279,800.001,221,416View SEC Filing  
8/17/2016Susan E BurwigInsiderBuy19,211$29.21$561,153.311,211View SEC Filing  
8/16/2016August J TroendleCEOBuy869,565$23.00$19,999,995.001,221,416View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Medpace (NASDAQ MEDP) News Headlines

Source:
DateHeadline
 Analysts Expect Medpace Holdings (MEDP) Will Post Quarterly Sales of $102.66 Million Analysts Expect Medpace Holdings (MEDP) Will Post Quarterly Sales of $102.66 Million
www.americanbankingnews.com - May 13 at 2:34 AM
Zacks: Analysts Expect Medpace Holdings (MEDP) to Announce $0.42 EPSZacks: Analysts Expect Medpace Holdings (MEDP) to Announce $0.42 EPS
www.americanbankingnews.com - May 11 at 5:37 PM
Medpace Holdings (MEDP) Major Shareholder Medpace Limited Partnership Sells 3,000,000 SharesMedpace Holdings (MEDP) Major Shareholder Medpace Limited Partnership Sells 3,000,000 Shares
www.americanbankingnews.com - May 8 at 7:22 PM
Medpace Holdings (MEDP) Expected to Post Q4 2018 Earnings of $0.50 Per ShareMedpace Holdings (MEDP) Expected to Post Q4 2018 Earnings of $0.50 Per Share
www.americanbankingnews.com - May 4 at 8:37 AM
Q3 2018 Earnings Estimate for Medpace Holdings (MEDP) Issued By Jefferies GroupQ3 2018 Earnings Estimate for Medpace Holdings (MEDP) Issued By Jefferies Group
www.americanbankingnews.com - May 4 at 7:41 AM
Q2 2018 Earnings Forecast for Medpace Holdings Issued By KeyCorp (MEDP)Q2 2018 Earnings Forecast for Medpace Holdings Issued By KeyCorp (MEDP)
www.americanbankingnews.com - May 4 at 7:36 AM
Medpace stock dips as it reveals secondary offeringMedpace stock dips as it reveals secondary offering
finance.yahoo.com - May 3 at 4:09 PM
Medpace Holdings (MEDP) Announces 3M Share Secondary Offering of Common Stock by Selling ShareholderMedpace Holdings (MEDP) Announces 3M Share Secondary Offering of Common Stock by Selling Shareholder
www.streetinsider.com - May 3 at 9:40 AM
Ritter Pharmaceuticals Selects Medpace as its Clinical Research Organization for Pivotal Phase 3 Clinical Trial of RP-G28 in Lactose IntoleranceRitter Pharmaceuticals Selects Medpace as its Clinical Research Organization for Pivotal Phase 3 Clinical Trial of RP-G28 in Lactose Intolerance
www.nasdaq.com - May 3 at 9:40 AM
Ritter Pharma engages Medpace to conduct late-stage study of RP-G28 in lactose intolerance; shares up 10% premarketRitter Pharma engages Medpace to conduct late-stage study of RP-G28 in lactose intolerance; shares up 10% premarket
seekingalpha.com - May 3 at 9:40 AM
Medpace Holdings, Inc. Announces Secondary Offering of Common Stock by Selling ShareholderMedpace Holdings, Inc. Announces Secondary Offering of Common Stock by Selling Shareholder
www.bizjournals.com - May 3 at 9:40 AM
William Blair Comments on Medpace Holdings Q2 2018 Earnings (MEDP)William Blair Comments on Medpace Holdings' Q2 2018 Earnings (MEDP)
www.americanbankingnews.com - May 3 at 8:17 AM
Q2 2018 Earnings Forecast for Medpace Holdings Issued By Jefferies Group (MEDP)Q2 2018 Earnings Forecast for Medpace Holdings Issued By Jefferies Group (MEDP)
www.americanbankingnews.com - May 3 at 8:17 AM
Medpace (MEDP) Upgraded by ValuEngine to "Buy"Medpace (MEDP) Upgraded by ValuEngine to "Buy"
www.americanbankingnews.com - May 2 at 11:33 PM
Medpace Holdings 2018 Q1 - Results - Earnings Call SlidesMedpace Holdings 2018 Q1 - Results - Earnings Call Slides
seekingalpha.com - May 2 at 4:14 PM
Medpace (MEDP) Downgraded to "Sell" at Zacks Investment ResearchMedpace (MEDP) Downgraded to "Sell" at Zacks Investment Research
www.americanbankingnews.com - May 2 at 12:54 PM
Edited Transcript of MEDP earnings conference call or presentation 1-May-18 1:00pm GMTEdited Transcript of MEDP earnings conference call or presentation 1-May-18 1:00pm GMT
finance.yahoo.com - May 2 at 9:43 AM
Medpace Holdings to Post Q2 2018 Earnings of $0.40 Per Share, William Blair Forecasts (MEDP)Medpace Holdings to Post Q2 2018 Earnings of $0.40 Per Share, William Blair Forecasts (MEDP)
www.americanbankingnews.com - May 2 at 8:48 AM
Medpace Holdings (MEDP) CEO August Troendle on Q1 2018 Results - Earnings Call TranscriptMedpace Holdings' (MEDP) CEO August Troendle on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 1 at 4:09 PM
BRIEF-Medpace Holdings Q1 GAAP Earnings Per Share $0.45BRIEF-Medpace Holdings Q1 GAAP Earnings Per Share $0.45
www.reuters.com - May 1 at 9:48 AM
Medpace: 1Q Earnings SnapshotMedpace: 1Q Earnings Snapshot
finance.yahoo.com - May 1 at 9:48 AM
Medpace Holdings, Inc. Reports First Quarter 2018 ResultsMedpace Holdings, Inc. Reports First Quarter 2018 Results
finance.yahoo.com - May 1 at 9:48 AM
Medpace (MEDP) Announces Quarterly  Earnings ResultsMedpace (MEDP) Announces Quarterly Earnings Results
www.americanbankingnews.com - April 30 at 9:16 PM
Medpace (MEDP) Releases FY18 Earnings GuidanceMedpace (MEDP) Releases FY18 Earnings Guidance
www.americanbankingnews.com - April 30 at 5:34 PM
A Look At The Intrinsic Value Of Medpace Holdings Inc (NASDAQ:MEDP)A Look At The Intrinsic Value Of Medpace Holdings Inc (NASDAQ:MEDP)
finance.yahoo.com - April 30 at 10:01 AM
Medpace Holdings (MEDP) Receives Average Rating of "Hold" from AnalystsMedpace Holdings (MEDP) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - April 30 at 3:50 AM
Medpace Holdings, Inc. to Report First Quarter 2018 Financial Results on April 30, 2018Medpace Holdings, Inc. to Report First Quarter 2018 Financial Results on April 30, 2018
finance.yahoo.com - April 28 at 10:13 AM
 Analysts Anticipate Medpace Holdings (MEDP) Will Post Quarterly Sales of $99.93 Million Analysts Anticipate Medpace Holdings (MEDP) Will Post Quarterly Sales of $99.93 Million
www.americanbankingnews.com - April 26 at 4:34 AM
Medpace Holdings (MEDP) Expected to Announce Earnings of $0.43 Per ShareMedpace Holdings (MEDP) Expected to Announce Earnings of $0.43 Per Share
www.americanbankingnews.com - April 24 at 8:08 AM
Medpace (MEDP) Scheduled to Post Quarterly Earnings on MondayMedpace (MEDP) Scheduled to Post Quarterly Earnings on Monday
www.americanbankingnews.com - April 23 at 7:14 AM
Head-To-Head Analysis: Cleveland BioLabs (CBLI) & Medpace (MEDP)Head-To-Head Analysis: Cleveland BioLabs (CBLI) & Medpace (MEDP)
www.americanbankingnews.com - April 22 at 7:08 PM
Medpace (MEDP) Coverage Initiated at Mitsubishi UFJ Financial GroupMedpace (MEDP) Coverage Initiated at Mitsubishi UFJ Financial Group
www.americanbankingnews.com - April 20 at 10:25 AM
Wyndham (WYN) Launches Hotel Under Dolce Brand in CincinnatiWyndham (WYN) Launches Hotel Under Dolce Brand in Cincinnati
www.zacks.com - April 18 at 4:23 PM
Dolce Hotels and Resorts by Wyndham Debuts its First Cincinnati HotelDolce Hotels and Resorts by Wyndham Debuts its First Cincinnati Hotel
www.bizjournals.com - April 17 at 10:10 AM
Peek inside Cincinnati’s first Dolce Hotel: PHOTOSPeek inside Cincinnati’s first Dolce Hotel: PHOTOS
www.bizjournals.com - April 16 at 4:07 PM
Medpace Holdings Facing Some Challenges To A Model That Has Worked WellMedpace Holdings Facing Some Challenges To A Model That Has Worked Well
seekingalpha.com - April 14 at 10:01 AM
Medpace (MEDP) Raised to Hold at Zacks Investment ResearchMedpace (MEDP) Raised to Hold at Zacks Investment Research
www.americanbankingnews.com - April 13 at 11:43 PM
Medpace (MEDP) PT Set at $35.00 by Robert W. BairdMedpace (MEDP) PT Set at $35.00 by Robert W. Baird
www.americanbankingnews.com - April 10 at 9:16 AM
$99.93 Million in Sales Expected for Medpace Holdings (MEDP) This Quarter$99.93 Million in Sales Expected for Medpace Holdings (MEDP) This Quarter
www.americanbankingnews.com - April 9 at 3:42 AM
Medpace Holdings Inc (MEDP) Expected to Post Earnings of $0.43 Per ShareMedpace Holdings Inc (MEDP) Expected to Post Earnings of $0.43 Per Share
www.americanbankingnews.com - April 7 at 9:53 AM
KeyCorp Reiterates "Hold" Rating for Medpace (MEDP)KeyCorp Reiterates "Hold" Rating for Medpace (MEDP)
www.americanbankingnews.com - April 6 at 9:16 PM
Medpace (MEDP) Stock Rating Lowered by Zacks Investment ResearchMedpace (MEDP) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - April 5 at 11:52 PM
Medpace Holdings Inc (MEDP) Receives Consensus Rating of "Hold" from BrokeragesMedpace Holdings Inc (MEDP) Receives Consensus Rating of "Hold" from Brokerages
www.americanbankingnews.com - April 5 at 3:24 AM
Cincinnati stocks slammed by China trade battle; here’s what it meansCincinnati stocks slammed by China trade battle; here’s what it means
finance.yahoo.com - April 4 at 5:25 PM
Financial Survey: Medpace (MEDP) & BTG (BTGGF)Financial Survey: Medpace (MEDP) & BTG (BTGGF)
www.americanbankingnews.com - April 3 at 7:17 PM
Does Medpace Holdings Inc’s (NASDAQ:MEDP) PE Ratio Warrant A Buy?Does Medpace Holdings Inc’s (NASDAQ:MEDP) PE Ratio Warrant A Buy?
finance.yahoo.com - April 3 at 4:13 PM
William Blair Lowers Medpace (MEDP) to Market PerformWilliam Blair Lowers Medpace (MEDP) to Market Perform
www.americanbankingnews.com - April 2 at 1:31 PM
Medpace (MEDP) Given New $38.00 Price Target at Jefferies GroupMedpace (MEDP) Given New $38.00 Price Target at Jefferies Group
www.americanbankingnews.com - April 2 at 11:16 AM
Medpace (MEDP) Upgraded to "Buy" at Zacks Investment ResearchMedpace (MEDP) Upgraded to "Buy" at Zacks Investment Research
www.americanbankingnews.com - April 1 at 10:20 PM
Viralytics (VRACY) and Medpace (MEDP) Financial ReviewViralytics (VRACY) and Medpace (MEDP) Financial Review
www.americanbankingnews.com - April 1 at 1:26 AM

SEC Filings

Medpace (NASDAQ:MEDP) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Medpace (NASDAQ:MEDP) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Medpace (NASDAQ MEDP) Stock Chart for Sunday, May, 20, 2018

Loading chart…

This page was last updated on 5/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.